MECP2 and Rett syndrome: The aim of the study is to assess a possible association between MECP2 mutations or RTT disease progression and plasma levels of 4-F4t-NeuroP and 10-F4t-NeuroP in typical RTT patients harboring MECP2 gene mutations.